NSW Health reports 1,180 ER visits tied to unapproved peptides since July 2025
Monthly cases climbed from five to over 217 by September 2026. Officials name BPC-157, retatrutide and others, none approved in Australia, and cite kidney and liver injuries.
Recap by typeshit. Full story at NSW Government.